Cookie Consent by PrivacyPolicies.com
JAMA Network Open

Simulation of Pool Testing to Identify Patients With Coronavirus Disease 2019 Under Conditions of Limited Test Availability.

Alhaji Cherif, Nadja Grobe, Xiaoling Wang, Peter Kotanko

This decision analytical model study examines the feasibility of using pool testing to identify patients with coronavirus disease 2019 (COVID-19) in a setting with limited testing availability.

About the Contributors

Dr. Peter Kotanko, MD

RRI Research Director

SVP, Corporate Research & Development

Peter Kotanko, MD is Research Director at the Renal Research Institute (RRI), New York. Prior to joining RRI, from 1997 to 2007 he served as Vice Chair of a department of internal medicine at an academic teaching hospital in Graz, Austria. Prior to moving to Graz in 1989, he worked 1982-89 at the Department of Physiology and the University Clinic of Internal Medicine, Innsbruck, Austria...

Alhaji Cherif, D. Phil.

Senior Mathematician

Alhaji Cherif, D.Phil., is Senior Mathematician at the RRI with over 10 years of multi- and transdisciplinary research experiences in nanotechnology (microfluidics), adaptive complex systems, and applied mathematical sciences and its application in life, physical and social sciences. He leads the mathematical modeling efforts relevant to pathophysiological mechanisms in dialysis patients, particularly, acid-base disturbance, bone and mineral disease, cardiovascular calcification and anemia...

Nadja Grobe, MS, PhD

Supervisor, Laboratory Research

Dr. Nadja Grobe received her MS and PhD in Biochemistry from the Martin Luther University Halle Wittenberg, Germany. Prior to joining the RRI in 2017, she gained more than 10 years of experience in guiding and implementing chemistry, biochemistry, and biomedical-focused research teams in non-profit, academia, and government. Her previous research has been funded by the American Heart Association, National Institutes of Health, and the American Society of Nephrology...

Xiaoling Wang, PhD

Senior Research Scientist

Dr. Xiaoling Wang joined RRI in 2019. She received her PhD in Biochemistry and Structural Biology program at Stony Brook University. Prior to joining RRI, she had years of postdoctoral experiences at the Rockefeller University studying transcriptional regulation in vitro and in vivo...